Zoetis Share Holder Equity 2011-2025 | ZTS

Zoetis share holder equity from 2011 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Zoetis share holder equity for the quarter ending March 31, 2025 was $4.655B, a 7.86% decline year-over-year.
  • Zoetis share holder equity for 2024 was $4.77B, a 4.43% decline from 2023.
  • Zoetis share holder equity for 2023 was $4.991B, a 13.35% increase from 2022.
  • Zoetis share holder equity for 2022 was $4.403B, a 3.1% decline from 2021.
Zoetis Annual Share Holder Equity
(Millions of US $)
2024 $4,770
2023 $4,991
2022 $4,403
2021 $4,544
2020 $3,773
2019 $2,708
2018 $2,185
2017 $1,786
2016 $1,499
2015 $1,091
2014 $1,337
2013 $962
2012 $4,041
2011 $3,736
2010 $0
Zoetis Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $4,655
2024-12-31 $4,770
2024-09-30 $5,234
2024-06-30 $4,960
2024-03-31 $5,052
2023-12-31 $4,991
2023-09-30 $5,074
2023-06-30 $4,621
2023-03-31 $4,491
2022-12-31 $4,403
2022-09-30 $4,662
2022-06-30 $4,580
2022-03-31 $4,658
2021-12-31 $4,544
2021-09-30 $4,681
2021-06-30 $4,352
2021-03-31 $4,092
2020-12-31 $3,773
2020-09-30 $3,607
2020-06-30 $2,987
2020-03-31 $2,753
2019-12-31 $2,708
2019-09-30 $2,678
2019-06-30 $2,411
2019-03-31 $2,317
2018-12-31 $2,185
2018-09-30 $2,118
2018-06-30 $1,982
2018-03-31 $1,975
2017-12-31 $1,786
2017-09-30 $2,019
2017-06-30 $1,746
2017-03-31 $1,635
2016-12-31 $1,499
2016-09-30 $1,598
2016-06-30 $1,371
2016-03-31 $1,187
2015-12-31 $1,091
2015-09-30 $1,254
2015-06-30 $1,202
2015-03-31 $1,305
2014-12-31 $1,337
2014-09-30 $1,389
2014-06-30 $1,283
2014-03-31 $1,099
2013-12-31 $962
2013-09-30 $866
2013-06-30 $823
2013-03-31 $724
2012-12-31 $4,041
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $3,736
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $67.311B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.891B 28.47
Takeda Pharmaceutical (TAK) Japan $46.297B 9.21
Daiichi Sankyo, - (DSNKY) Japan $45.521B 23.33
BeOne Medicines - (ONC) Cayman Islands $32.397B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.766B 0.00
Summit Therapeutics (SMMT) United States $19.710B 0.00
Merck (MKKGY) Germany $16.653B 12.20
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.437B 11.89
Neurocrine Biosciences (NBIX) United States $13.138B 45.00
Orion OYJ (ORINY) Finland $11.666B 28.12
IPSEN (IPSEY) France $10.323B 0.00
Stevanato Group S.p.A (STVN) Italy $7.420B 45.37
Corcept Therapeutics (CORT) United States $7.326B 59.55
Madrigal Pharmaceuticals (MDGL) United States $6.959B 0.00
Ionis Pharmaceuticals (IONS) United States $6.677B 0.00
Grifols, S.A (GRFS) Spain $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.335B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
Hypermarcas (HYPMY) Brazil $3.034B 19.96
Crinetics Pharmaceuticals (CRNX) United States $2.853B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.574B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.549B 8.93
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
Centessa Pharmaceuticals (CNTA) United Kingdom $2.160B 0.00
Ocular Therapeutix (OCUL) United States $1.840B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.810B 0.00
ARS Pharmaceuticals (SPRY) United States $1.728B 0.00
Endo (NDOI) United States $1.603B 0.00
Harrow (HROW) United States $1.325B 0.00
Evotec AG (EVO) Germany $1.321B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 24.00
Avadel Pharmaceuticals (AVDL) Ireland $1.086B 0.00
Ardelyx (ARDX) United States $1.059B 0.00
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.047B 0.00
Collegium Pharmaceutical (COLL) United States $1.017B 5.48
Akebia Therapeutics (AKBA) United States $1.011B 0.00
Verve Therapeutics (VERV) United States $0.988B 0.00
ProKidney (PROK) United States $0.893B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.790B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.702B 0.00
Xencor (XNCR) United States $0.655B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Zevra Therapeutics (ZVRA) United States $0.633B 0.00
Organogenesis (ORGO) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
USANA Health Sciences (USNA) United States $0.587B 11.81
Theravance Biopharma (TBPH) United States $0.562B 0.00
Bioventus (BVS) United States $0.529B 13.42
Oruka Therapeutics (ORKA) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.484B 0.00
Savara (SVRA) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 9.69
Altimmune (ALT) United States $0.341B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
AleAnna (ANNA) United States $0.307B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.37
OmniAb (OABI) United States $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.240B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
China SXT Pharmaceuticals (SXTC) China $0.204B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
Profound Medical (PROF) Canada $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.175B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Lyell Immunopharma (LYEL) United States $0.152B 0.00
Liminatus Pharma (LIMN) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Cassava Sciences (SAVA) United States $0.125B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Nutriband (NTRB) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Fractyl Health (GUTS) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.026B 0.00
Incannex Healthcare (IXHL) Australia $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.41
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.46
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00